Active Substance: Haemophilus b conjugate vaccine (conjugated with diphtheria CRM197 protein).
Overview
Welcome to Dwaey, specifically on HIB TITER VACCINE page.
This medicine contains an important and useful components, as it consists of
Haemophilus b conjugate vaccine (conjugated with diphtheria CRM197 protein)is available in the market in concentration
Haemophilus Influenzae Type B Polysaccharide Vaccine
Minor illnesses such as upper respiratory infection with or without low-grade fever are not contraindications for use of HIB vaccine. As reported with Haemophilus b polysaccharide vaccines, cases of H influenzae type b disease may occur subsequent to vaccination and prior to the onset of protective effects of the vaccine. Medical supervision is needed. Lactation: Excretion in milk unknown
Haemophilus influenzae type b infection (meningitis, septicemia, cellulitis, arthritis).
Hypersensitivity
Irritability (72.6%), drowsiness (57.5%), tenderness (46.3%), induration (22.5%), fever (20.1%), anorexia (15.3%), diarrhea (4.4%) Frequency Not Defined Pain,Sleepiness,Rash,Vomiting Injection site erythema/induration/pain/soreness/warmth/swelling Otitis media,URI
3
Antigenic capsular polysaccharides induce Ab production.
Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs, and corticosteroids (used in greater than physiologic doses) may reduce the immune response to vaccine.
Information not available